These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 1905591)

  • 21. New drugs for treatment of ventricular arrhythmias.
    Heger JJ; Prystowsky EN; Zipes DP
    Heart Lung; 1981; 10(3):475-83. PubMed ID: 6785255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic drugs.
    Roy D
    Can Anaesth Soc J; 1986 May; 33(3 Pt 2):S65-7. PubMed ID: 2872953
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia.
    Wichter T; Borggrefe M; Haverkamp W; Chen X; Breithardt G
    Circulation; 1992 Jul; 86(1):29-37. PubMed ID: 1617780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiarrhythmic efficacy of encainide and quinidine: validation of a model for drug assessment.
    Sami M; Harrison DC; Kraemer H; Houston N; Shimasaki C; DeBusk RF
    Am J Cardiol; 1981 Jul; 48(1):147-56. PubMed ID: 6787910
    [No Abstract]   [Full Text] [Related]  

  • 26. New directions in antiarrhythmic drug therapy.
    Somberg JC
    Am J Cardiol; 1984 Aug; 54(4):8B-17B. PubMed ID: 6147082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiologic effects and predictors of success of combination therapy with class Ia and Ib antiarrhythmic drugs for sustained ventricular arrhythmias.
    Foster MT; Peters RW; Froman D; Shorofsky SR; Gold MR
    Am J Cardiol; 1996 Jul; 78(1):47-50. PubMed ID: 8712117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
    Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
    Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
    Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy with investigational antiarrhythmic drugs.
    Mead RH; Harrison DC
    Med Clin North Am; 1984 Sep; 68(5):1321-37. PubMed ID: 6436596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia.
    Marchlinski FE; Buxton AE; Miller JM; Vassallo JA; Flores BT; Josephson ME
    Circulation; 1986 Nov; 74(5):1037-43. PubMed ID: 3769163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
    Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
    Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of oral quinidine-mexiletine combination therapy for sustained ventricular tachyarrhythmias as assessed by programmed electrical stimulation when quinidine monotherapy has failed.
    Bonavita GJ; Pires LA; Wagshal AB; Cuello C; Mittleman RS; Greene TO; Huang SK
    Am Heart J; 1994 Apr; 127(4 Pt 1):847-51. PubMed ID: 8154423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia.
    Dorian P; Newman D; Berman N; Hardy J; Mitchell J
    J Am Coll Cardiol; 1993 Jul; 22(1):106-13. PubMed ID: 8509529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic drug therapy. Recent advances and current status.
    Somberg J
    Cardiology; 1985; 72(5-6):329-48. PubMed ID: 2866841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
    Greenspan AM; Spielman SR; Horowitz LN
    Pacing Clin Electrophysiol; 1986 Jul; 9(4):565-76. PubMed ID: 2426675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
    Nestico PF; Morganroth J
    Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newer antiarrhythmic drugs in children.
    Moak JP; Smith RT; Garson A
    Am Heart J; 1987 Jan; 113(1):179-85. PubMed ID: 3099560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of antiarrhythmic drug effects by epinephrine: quinidine versus amiodarone.
    Calkins H; Sousa J; el-Atassi R; Schmaltz S; Kadish A; Morady F
    J Am Coll Cardiol; 1992 Feb; 19(2):347-52. PubMed ID: 1732363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classification of antiarrhythmic agents: electropharmacologic basis and clinical relevance.
    Coromilas J
    Cardiovasc Clin; 1992; 22(1):97-116. PubMed ID: 1309443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.